Ignite Creation Date:
2025-12-25 @ 4:18 AM
Ignite Modification Date:
2026-03-02 @ 4:09 PM
Study NCT ID:
NCT02220920
Status:
COMPLETED
Last Update Posted:
2016-12-15
First Post:
2014-08-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety Study of Canagliflozin (TA-7284) in Combination With Insulin in Patients With Type 2 Diabetes Mellitus
Sponsor:
Tanabe Pharma Corporation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-08
Start Date Type:
None
Primary Completion Date:
2015-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-07
Completion Date Type:
ACTUAL
First Submit Date:
2014-08-19
First Submit QC Date:
None
Study First Post Date:
2014-08-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-08-03
Results First Submit QC Date:
None
Results First Post Date:
2016-12-15
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-10-24
Last Update Post Date:
2016-12-15
Last Update Post Date Type:
ESTIMATED